PwC recently released its Global Pharma & Life Sciences Deals Insight report. The following are some quick highlights from the report relative to the medical device sector.
The firm listed the top 12 deals in pharma and lifesciences in 2019; two medical device deals made the list. The billion-dollar acquisitions were: Acelity, Inc. by 3M and Stryker’s acquisition of Wright Medical Group.
Last year the medical device industry saw a decline in deal value and volume. The report states that medtech companies may be going back to the drawing board to internally figure out the management of payor and provider relationships before moving forward on inorganic expansion. However, PwC’s sub-sector analysis anticipates that the value and volume of deals will go up this year, including the potential for deals between $2–$5 billion in the medical device segment.